期刊文献+

β-catenin在子宫内膜癌组织中的研究 被引量:1

The study on the expression of β-catenin in endometrial carcinoma tissue
下载PDF
导出
摘要 目的探讨β-catenin在子宫内膜癌组织中的表达情况及其与子宫内膜癌发展及转移的关系。方法选择子宫内膜癌手术患者的手术切除标本80例及正常子宫内膜手术切除标本20例,采用免疫组织化学S-P法检测β-catenin的表达,分析其在组织中表达的差异及其与临床病理特征的关系。结果在子宫内膜癌组织中β-catenin蛋白的阳性表达率明显高于正常子宫内膜组织(P<0.05),在不同组织病理分级中的表达结果 :G1级的阳性率为86.9%,G2级的阳性表达率为80.6%,G3级的阳性表达率为42.3%,三者之间差异有统计学意义(P<0.05);子宫肌层浸润<1/2病例的阳性率为56.5%,肌层浸润≥1/2者阳性率为87.3%,两者差异有统计学意义(P<0.05);淋巴结转移阴性的病例中的阳性率为59.3%,淋巴结转移阳性者为84.6%,两者之间差异有统计学意义(P<0.05);手术病理分期Ⅰ期的阳性率为63.6%,Ⅱ期的阳性率为77.3%;Ⅲ期的阳性率为80.0%,Ⅰ期与Ⅱ期差异有统计学意义(P<0.05),Ⅱ期与Ⅲ期差异无统计学意义(P>0.05)。结论β-catenin在子宫内膜癌组织中呈高表达,且与组织分级、子宫肌层浸润及淋巴结转移有关,表明β-catenin在子宫内膜癌的发生、发展、侵袭及转移中发挥作用。 Objective To investigate the expression of β-catenin in the tissue of endometrial cancer,and to explore the relationship between the expression of β-catenin and the development,metastasis of endometrial cancer.Methods The expression of β-catenin was detected in 80 specimens of surgical ablation from the patients with endometrial carcinoma and 20 specimens of surgical ablation from healthy subjects by immunocytochemisory (SP),and the relationship between the expression of β-catenin and the clinical pathological characteristics was analyzed.Results The expression of β-catenin in endometrial carcinoma tissue was significantly higher than that of normal endometrial tissue (P0.05).The expression of β-catenin was different in different pathological grades.The positive rate of β-catenin expression was 86.9% in grade Ⅰ;80.6% in grade Ⅱ;42.3% in grade Ⅲ,there were significant differences among the three grades(P0.05).The positive rate ofβ-catenin expression was 56.5% in 1/2 tissue of endometrial cancer with myometrium infiltration,which was 87.3% in ≥1/2 tissue of endometrial cancer with myometrium infiltration,there was a significant difference between the two kinds of tissues(P0.05).The positive rate of tissue without lymph node metastasis was 59.3%,however,which with lymph node metastasis was 84.6%,there was a significant difference between them(P0.05).The expression of β-catenin was different in different pathological stages,63.6% in stageⅠ;77.3% in stageⅡ;80.0% in stage Ⅲ,there was a significant difference between the stage Ⅰ and Ⅱ(P0.05),there was no significast difference between stage Ⅱ and Ⅲ(P0.05).Conclusion The β-catenin is over expressed in the tissue of endomertrium carcinoma,which is related with pathological classification,myometrium infiltration and lymph node matastasis.β-catenin playes an important role in carcinogenesis,development,infiltration and metastasis of carcinoma of endometrium.
出处 《河北医药》 CAS 2010年第17期2320-2322,共3页 Hebei Medical Journal
关键词 子宫内膜癌 Β-CATENIN 免疫组化 carcinoma of endomerium β-catenin immunocytochemistry
  • 相关文献

参考文献7

  • 1李敏,徐金秀,杨素勉,霍密英,李荣霞.子宫内膜癌患者外周血内皮抑素的测定[J].河北医药,2008,30(8):1158-1159. 被引量:1
  • 2Sherman ME.Theories of endometrial carcinogenesis:a multidisciplinary approach.Mod Pathol,2000,13:195-308.
  • 3Saegusa M,Hashimura M,Yoshida T,et al.Bate-catenin mutations and aberrant nucler expression during endometrial tumorigenesis.Cancer,2004,84:209-217.
  • 4Stefansson,Ingunn m,Salvesen,et al.Prognostic Impact of Alterations n P-Cadherin Expression and Related Cell Adhesion Marker in Endometrial Cancer.Journal of Clinical Oncology,2004,22:1242-1252.
  • 5Schlosshauer PW,Ellenson LH,Soslow RA.Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype.Mod Pathol,2002,15:1032-1037.
  • 6Machin P,Catasus L,Pons C,et al.CTNNBI mutations and betar-catenin expression in endometrial carcinomas.Hum Pathol,2002,33:206-212.
  • 7刘霞,张为远,代荫梅.子宫内膜癌相关危险因素研究进展[J].中国全科医学,2009,12(12):1128-1131. 被引量:23

二级参考文献28

  • 1杨林,王金万,汤仲明,刘秀文,黄镜,李树婷,董英,张和平,薛岚,储大同,孙燕.重组人血管内皮抑制素Ⅰ期临床研究[J].中国新药杂志,2004,13(6):548-553. 被引量:154
  • 2高静 ,项永兵 ,徐望红 ,邵常霞 ,阮志贤 ,程家蓉 ,SHU Xiao-ou ,高玉堂 .绿茶与子宫内膜癌关系的病例对照研究[J].中华流行病学杂志,2005,26(5):323-327. 被引量:7
  • 3[1]Jemal A,Thomas A,Murray T,et al.Cancer statistics,2002[J].CA Cancer J Clin,2002,52(1):23-47.
  • 4[2]Sang ML,Jong RH,Tae SJ,et al.A case of Cushing′s syndrome presenting as endometrial hyperplasia[J].The Korean Journal of Internal Medicine,2008,23(1):49-52.
  • 5[3]The Writing Group for the PEPl Trial.Effects of hormone replacement therapy on endometrial histology in postmenopausal women.The Postmenopausal Estrogen/Progestin Interventions(PEPI)Trial[J].JAMA,1996,275(5):370-375.
  • 6[4]Yamazawa K,Miyazawa Y,Suzuki M,et al.Tamoxifen and the risk of endometrial cancer in Japanese women with breast cancer[J].Surg Today,2006,36(1):41-46.
  • 7[5]Weiderpass E,Adami HO,Baron JA,et al.Use of oral contraceptives and endometrial cancer risk (Sweden)[J].Cancer Causes Control,1999,10(4):277-284.
  • 8[7]Flemming R,Sathiyathasan S,Jackson A,et al.Endometrioid adenocarcinoma after insertion of a levonorgestrel-releasing intrauterine system[J].J Minim Invasive Gynecol,2008,15(6):771-773.
  • 9[8]Beining RM,Dennis LK,Smith EM,et al.Meta-analysis of intrauterine device and risk of endometrial cancer[J].Ann Epidemiol,2008,18(6):492-499.
  • 10[9]Lindemann K,Vatten LJ,Ellstrm-Engh M,et al.Body mass,diabetes and smoking,and endometrial cancer risk:a follow-up study[J].Br J Cancer,2008,98(9):1582-1585.

共引文献22

同被引文献20

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部